Insider: Dunlop A. Sinclair Director - Apellis Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 122,403 | 68,908 | 191,311 |
| Value | $2,738,155.11 | $1,541,471.96 | $4,279,627.07 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/19/2025 | DDS | 31,092 | Indirect | COM | $22.95 | $713,561.40 | 68,908 |
| 09/16/2024 | DDS | 29,476 | Indirect | COM | $36.09 | $1,063,788.84 | 107,524 |
| 09/16/2024 | DDS | 7,524 | Indirect | COM | $36.79 | $276,807.96 | 100,000 |
| 06/21/2024 | DDS | 35,305 | Indirect | COM | $39.22 | $1,384,662.10 | 138,693 |
| 06/21/2024 | DDS | 1,695 | Indirect | COM | $39.63 | $67,172.85 | 136,998 |
| 03/19/2024 | DDS | 18,681 | Indirect | COM | $57.18 | $1,068,160.90 | 173,998 |
| 12/01/2023 | DDS | 24,000 | Indirect | COM | $61.14 | $1,467,240.00 | 192,679 |
| 11/17/2023 | DDS | 8,894 | Direct | COM | $49.99 | $444,619.95 | 122,403 |
| 10/17/2023 | DDS | 24,000 | Indirect | COM | $49.00 | $1,176,000.00 | 216,679 |
| 04/03/2023 | DDS | 500 | Direct | COM | $74.05 | $37,025.00 | 131,297 |
| 03/01/2023 | DDS | 500 | Direct | COM | $65.33 | $32,665.00 | 131,797 |
| 02/01/2023 | DDS | 500 | Direct | COM | $52.61 | $26,305.00 | 132,297 |
| 01/03/2023 | DDS | 500 | Direct | COM | $50.70 | $25,350.00 | 132,797 |
| 12/01/2022 | DDS | 500 | Direct | COM | $49.93 | $24,965.00 | 129,430 |
| 11/01/2022 | DDS | 500 | Direct | COM | $60.83 | $30,415.00 | 129,930 |
| 09/08/2022 | DDS | 15,000 | Indirect | COM | $65.00 | $975,000.00 | 240,679 |
| 08/11/2022 | DDS | 30,000 | Indirect | COM | $65.63 | $1,968,900.00 | 255,679 |
| 06/27/2022 | DDS | 1,341 | Indirect | COM | $46.79 | $62,742.84 | 1,341 |
| 06/23/2022 | DDS | 15,000 | Indirect | COM | $45.00 | $675,000.00 | 285,679 |
| 05/20/2021 | DDS | 5,773 | Indirect | COM | $48.10 | $277,681.30 | 31,855 |
| 05/19/2021 | DDS | 7,612 | Indirect | COM | $50.00 | $380,600.00 | 300,679 |
| 05/18/2021 | DDS | 36,387 | Indirect | COM | $53.78 | $1,956,892.86 | 59,946 |
| 05/18/2021 | DDS | 64,179 | Indirect | COM | $51.66 | $3,315,487.14 | 110,549 |
| 05/18/2021 | DDS | 14,216 | Indirect | COM | $52.63 | $748,188.08 | 96,333 |
| 05/18/2021 | DDS | 22,318 | Indirect | COM | $54.57 | $1,217,893.26 | 37,628 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research